GM

Gurusamy Muralitharan

Active Director Additional Director DIN 10783746
DIN 10783746 First appointment Sep 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurusamy Muralitharan

Data last updated:

Gurusamy Muralitharan is an Additional Director at Meu Amor Life Sciences Private Limited (since 2024).

DIN 10783746
Primary Designation Additional Director
First Appointment 23 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director23 Sep 20242024Active

Board colleagues of Gurusamy Muralitharan

Directorship timeline

Open interactive timeline →
Meu Amor Life Sciences Private Limited
Premium access

Shareholding and investment profile for Gurusamy Muralitharan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurusamy Muralitharan

Gurusamy Muralitharan currently holds 1 directorship: Meu Amor Life Sciences Private Limited (Additional Director, since 23 Sep 2024).

Gurusamy Muralitharan was first appointed on 23 Sep 2024 as Additional Director at Meu Amor Life Sciences Private Limited.

The current boards of Gurusamy Muralitharan's companies include Balusamy Bharathy Mohan (Meu Amor Life Sciences Private Limited), Kothandapani Elanchezhiyan (Meu Amor Life Sciences Private Limited), Murali (Meu Amor Life Sciences Private Limited), Ramesh Jeyaraja (Meu Amor Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available